US equities |
NVDA $239.43 ▲+2.34% SPCX $170.03 ▲+6.96% MU $1,062.57 ▼-1.15% TSLA $379.84 ▲+2.50% SNDK $1,702.44 ▼-1.02% MSFT $527.05 ▲+1.84% INTC $116.25 ▼-2.58% META $742.76 ▲+2.02%
FinancialContent

Articles published by Nuvation Bio and Eisai

News headline image
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
From Nuvation Bio and Eisai
Via Business Wire
Tickers NUVB